GRRMF Stock: Gerresheimer AG Stock Price, Analysis & Insights
Get live GRRMF stock price $32.10, comprehensive Gerresheimer AG stock analysis, charts, news, and expert forecast. Real-time GRRMF stock data and investment insights.
Loading chart data...
Gerresheimer AG (GRRMF) Overview
Gerresheimer AG (GRRMF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Instruments & Supplies industry . As of the latest trading session, GRRMF trades at $32.10 with a market capitalization of 1.11B . Over the past 52 weeks, GRRMF has traded between $19.16 and $73.80 , with the current price positioned at approximately 24% of this range . The stock cu...
Key Takeaways
- Operates in the Healthcare sector (Medical - Instruments & Supplies)
- Market cap: 1.11B
- Current price: $32.10
- 52-week range: $19.16 - $73.80
- P/E ratio: 40.63
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Gerresheimer AG, alongside its global subsidiaries, stands as a prominent manufacturer of packaging solutions and drug delivery devices. The company's operations are segmented into three primary divisions. The Plastics & Devices division supplies a c...
Company Information
- CEO
- Uwe Ferdinand Röehrhoff
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 13632
Contact Information
- Website
- https://www.gerresheimer.com
- Address
- Klaus-Bungert-Strasse 4
- Country
- DE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 40.6)
✓ Lower volatility stock (Beta: 0.47) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Gerresheimer AG shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Gerresheimer AG
- ⚠Investors should consider how Gerresheimer AG fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 40.6) requires strong growth to justify
Market Cap
1.11B
P/E Ratio (TTM)
40.63
Beta
0.47
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare GRRMF with peer companies:
- Price
- $24.99
- Market cap
- 1.65B
- Price
- $26.00
- Market cap
- 1.33B
- Price
- $6.50
- Market cap
- 2.39B
- Price
- $5.55
- Market cap
- 2.12B
- Price
- $31.07
- Market cap
- 2.06B
- Price
- $8.67
- Market cap
- 2.02B
- Price
- $14.00
- Market cap
- 997.75M
- Price
- $5.51
- Market cap
- 1.67B
- Price
- $30.30
- Market cap
- 1.72B
- Price
- $10.24
- Market cap
- 497.86M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.